Stuff...Much of the recent buying is being done by long term shareholders. I think that the efforts to accurately inform shareholders, to whatever degree accuracy has been achieved, have helped shareholders retain confidence in Bioasis. This will show itself as the story unfolds when the usual broad selling on news turns out to be limited because shareholders retain high expectations for Bioasis.
I think this confidence is warranted.
Keep an eye on Johnson & Johnson. That company's spin off of its commercial products division and the reduced baby-powder legal liabilities that the remaining J&J may face could result in some interesting initiatives on J&J's and subsidiary Janssen's parts. In addition to long rumoured activities between Bioasis and the J&J companies, there were some interesting comments made by J&J at the Sachs & Associates Alzheimer's Progress conference that Bioasis attended in May. J&J's comments seemed tailormade for Bioasis's strategic plan.
The Bioasis information circular and other AGM documents have been available for a day or two on SEDAR.
I wouldn't expect to see news coming out between the dates that AGM voting starts and the AGM. News at any point from now on would mean that early shareholders may be voting without the same information that later voters would have. There may be a regulation about that but I have never read it if it exists.
Happy voting, everybody. I recommend full support for the whole thing. I have never seen Bioasis in such good shape as it is right now. The market hasn't quite grasped that yet but it will if DrDR delivers as seems both apparent and imminent.
jd